These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1767805)

  • 1. Quinolone toxicity: methods of assessment.
    Patterson DR
    Am J Med; 1991 Dec; 91(6A):35S-37S. PubMed ID: 1767805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of organ-specific toxicity of temafloxacin in animals and humans.
    Krasula RW; Pernet AG
    Am J Med; 1991 Dec; 91(6A):38S-41S. PubMed ID: 1662894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of temafloxacin neurotoxicity in rodents.
    Giardina WJ
    Am J Med; 1991 Dec; 91(6A):42S-44S. PubMed ID: 1662895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of the repeat dose toxicity of grepafloxacin and a number of other fluoroquinolones in rats.
    Takizawa T; Hasimoto K; Itoh N; Yamashita S; Owen K
    Hum Exp Toxicol; 1999 Jan; 18(1):38-45. PubMed ID: 10025367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Side-effects of quinolones: comparisons between quinolones and other antibiotics.
    Norrby SR
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):378-83. PubMed ID: 1864300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerability of fluoroquinolone antibiotics. Past, present and future.
    Ball P; Tillotson G
    Drug Saf; 1995 Dec; 13(6):343-58. PubMed ID: 8652079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative articular toxicity of garenoxacin, a novel quinolone antimicrobial agent, in juvenile beagle dogs.
    Nagai A; Miyazaki M; Morita T; Furubo S; Kizawa K; Fukumoto H; Sanzen T; Hayakawa H; Kawamura Y
    J Toxicol Sci; 2002 Aug; 27(3):219-28. PubMed ID: 12238145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of the fluoroquinolone antibiotics.
    Just PM
    Pharmacotherapy; 1993; 13(2 Pt 2):4S-17S. PubMed ID: 8386356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety profile of the quinolones.
    Stahlmann R
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():31-44. PubMed ID: 2286589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific toxicologic aspects of the quinolones.
    Christ W; Lehnert T; Ulbrich B
    Rev Infect Dis; 1988; 10 Suppl 1():S141-6. PubMed ID: 3279489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions with quinolone antibacterials.
    Brouwers JR
    Drug Saf; 1992; 7(4):268-81. PubMed ID: 1524699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and expression of mutational resistance to the 4-quinolone antibacterials.
    Smith JT
    Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring database.
    Clark DW; Layton D; Wilton LV; Pearce GL; Shakir SA
    Drug Saf; 2001; 24(15):1143-54. PubMed ID: 11772147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluoroquinolone adverse effects and drug interactions.
    Fish DN
    Pharmacotherapy; 2001 Oct; 21(10 Pt 2):253S-272S. PubMed ID: 11642691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In-vitro activities of temafloxacin, tosufloxacin (A-61827) and five other fluoroquinolone agents.
    Barry AL; Jones RN
    J Antimicrob Chemother; 1989 Apr; 23(4):527-35. PubMed ID: 2745259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety profile of the fluoroquinolones.
    Bertino J; Fish D
    Clin Ther; 2000 Jul; 22(7):798-817; discussion 797. PubMed ID: 10945507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central nervous system toxicity of quinolones: human and animal findings.
    Christ W
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():219-25. PubMed ID: 2124211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The in-vitro activity of temafloxacin compared with other antimicrobial agents.
    King A; Bethune L; Phillips I
    J Antimicrob Chemother; 1991 Jun; 27(6):769-79. PubMed ID: 1657855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of renal function on the pharmacokinetics of lomefloxacin compared with other fluoroquinolones.
    Blum RA
    Am J Med; 1992 Apr; 92(4A):18S-21S. PubMed ID: 1316065
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.